Camex Limited (BOM:524440)
India · Delayed Price · Currency is INR 40.77
+1.71 (4.38%)
At close: Jul 30, 2025
Verve Therapeutics Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 23.83 | 91.49 | - | 12.57 | 3.88 | Upgrade |
Cash & Short-Term Investments | 23.83 | 91.49 | - | 12.57 | 3.88 | Upgrade |
Cash Growth | -73.96% | - | - | 223.75% | -10.33% | Upgrade |
Accounts Receivable | 218.8 | 237.45 | - | 326.91 | 419.73 | Upgrade |
Other Receivables | 3.41 | 1.96 | - | 18.3 | 6.16 | Upgrade |
Receivables | 266.15 | 310.01 | - | 385.37 | 426.16 | Upgrade |
Inventory | 131.3 | 80.88 | - | 136.69 | 157.23 | Upgrade |
Prepaid Expenses | 10.24 | 2.68 | - | 0.33 | 2.1 | Upgrade |
Restricted Cash | 3.66 | 6.64 | - | 0.39 | 1.06 | Upgrade |
Other Current Assets | 101.63 | 74.33 | - | 80.79 | 132.21 | Upgrade |
Total Current Assets | 536.8 | 566.03 | - | 616.13 | 722.64 | Upgrade |
Property, Plant & Equipment | 77.47 | 21.77 | - | 30.41 | 79.63 | Upgrade |
Long-Term Investments | 0.05 | 0.09 | - | 0.09 | 0.09 | Upgrade |
Other Intangible Assets | 0.2 | 0.22 | - | - | - | Upgrade |
Other Long-Term Assets | 0.26 | 26.6 | - | 1 | 2 | Upgrade |
Total Assets | 615.33 | 614.71 | - | 650.28 | 807.35 | Upgrade |
Accounts Payable | 160.87 | 113.71 | - | 144.71 | 276.01 | Upgrade |
Accrued Expenses | 6.34 | 6.07 | - | 8.22 | 6.67 | Upgrade |
Short-Term Debt | - | - | - | 1.41 | 105.35 | Upgrade |
Current Portion of Leases | 2.27 | - | - | - | - | Upgrade |
Current Income Taxes Payable | - | 3.8 | - | 7.88 | 0.33 | Upgrade |
Current Unearned Revenue | 4.93 | 2.87 | - | - | - | Upgrade |
Other Current Liabilities | 0.04 | 0.07 | - | 2.53 | 2.63 | Upgrade |
Total Current Liabilities | 174.45 | 126.51 | - | 164.75 | 390.99 | Upgrade |
Long-Term Debt | - | 76.19 | - | 85.18 | 68.37 | Upgrade |
Long-Term Leases | 9.97 | - | - | - | - | Upgrade |
Long-Term Deferred Tax Liabilities | 2.66 | 2.49 | - | 2.75 | 8.63 | Upgrade |
Other Long-Term Liabilities | - | 0 | - | - | -0 | Upgrade |
Total Liabilities | 187.08 | 205.19 | - | 252.68 | 467.98 | Upgrade |
Common Stock | 102.09 | 102.09 | - | 102.09 | 102.09 | Upgrade |
Additional Paid-In Capital | 18.85 | 18.85 | - | 18.85 | 18.85 | Upgrade |
Retained Earnings | 305.96 | 287.03 | - | 250.72 | 218.43 | Upgrade |
Comprehensive Income & Other | 1.35 | 1.56 | - | - | - | Upgrade |
Total Common Equity | 428.25 | 409.52 | - | 371.66 | 339.37 | Upgrade |
Minority Interest | - | - | - | 25.94 | - | Upgrade |
Shareholders' Equity | 428.25 | 409.52 | - | 397.6 | 339.37 | Upgrade |
Total Liabilities & Equity | 615.33 | 614.71 | - | 650.28 | 807.35 | Upgrade |
Total Debt | 12.24 | 76.19 | - | 86.59 | 173.71 | Upgrade |
Net Cash (Debt) | 11.58 | 15.3 | - | -74.02 | -169.83 | Upgrade |
Net Cash Growth | -24.29% | - | - | - | - | Upgrade |
Net Cash Per Share | 1.13 | 1.50 | - | -7.25 | -16.64 | Upgrade |
Filing Date Shares Outstanding | 10.21 | 10.21 | 10.21 | 10.21 | 10.21 | Upgrade |
Total Common Shares Outstanding | 10.21 | 10.21 | 10.21 | 10.21 | 10.21 | Upgrade |
Working Capital | 362.35 | 439.52 | - | 451.38 | 331.66 | Upgrade |
Book Value Per Share | 41.95 | 40.12 | - | 36.41 | 33.24 | Upgrade |
Tangible Book Value | 428.05 | 409.3 | - | 371.66 | 339.37 | Upgrade |
Tangible Book Value Per Share | 41.93 | 40.09 | - | 36.41 | 33.24 | Upgrade |
Land | 27.78 | - | - | - | 1.16 | Upgrade |
Buildings | 0.53 | 1.33 | - | 1.33 | 28.9 | Upgrade |
Machinery | 52.05 | 45.38 | - | 50.55 | 134.65 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.